Johnson & Johnson Innovation
Corporate venture firm · Founded 1973 · New Brunswick, NJ
Johnson & Johnson's innovation arm; its venture investing unit, Johnson & Johnson Innovation – JJDC (founded in 1973 as Johnson & Johnson Development Corporation), is described as the world's longest-surviving corporate venturing program, investing across medical devices, diagnostics, pharmaceuticals and biotechnology.
Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
This profile is unclaimed. Built from public sources. If you're a partner or employee at Johnson & Johnson Innovation, you can claim it.
Claim this profileHow claiming worksKey numbers
Assets under management
LAST CHECKED NOV 2026
Latest fund
LAST CHECKED NOV 2026
Funds
LAST CHECKED NOV 2026
Check size
LAST CHECKED NOV 2026
Stages
SeedSeries ASeries BGrowth
Sectors
healthcarebiotechnologymedical devicespharmaceuticals
FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG
Track record
Hits
- Legend Biotechipo
Cell-therapy company backed by JJDC that listed on Nasdaq in 2020; cited in GCV's Powerlist profile of JJDC's president.
Source: globalventuring.com
Misses
Track record
Partners 8
- Chris Picariello
President, Johnson & Johnson Innovation – JJDC
Board seats
No public record - Renee Ryan
Vice President, Venture Investments, Johnson & Johnson Innovation – JJDC
Board seats
No public record - Bo Liu
Partner
Board seats
No public record - Nadiya Ishnazarova
Partner
Board seats
No public record - Fiona Maclaughlin
Principal
Board seats
No public record - Zeev Zehavi
Principal
Board seats
No public record - Asish Xavier
Principal
Board seats
No public record - Hirak Parikh
Principal
Board seats
No public record
Reputation 1
No reputation score — basis not established for this firm.
- GCV Powerlist 2022: Chris Picariello
globalventuring.com
Contact
Published sources only
Published contact
- Website
- jnjinnovation.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
SOURCE: FIRM WEBSITE, AS PUBLISHED 2
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Johnson & Johnson Innovation. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewMethodology
Tier basis — Balance-sheet CVC with no disclosed fund AUM; Tier 3 via clear sector leadership (longest-surviving healthcare CVC, 150+ active portfolio companies in 2021 per GCV) with a sourced IPO hit (Legend Biotech). Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.
The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.
Source record 2
- [1]
DATABASE · GlassVC catalog — Catalog record for Johnson & Johnson Innovation — provenance: GlassVC extended catalog, November 2026
↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Track record · Reputation
- [2]
FIRM SITE · Johnson & Johnson Innovation — Firm website, as published by the firm
PROFILE BUILT FROM PUBLIC SOURCES · 2 CATALOG SOURCES · LAST CHECKED NOV 2026
